← Eichor
Study identifier: NCT05851989 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on Prognosis of Acutely Ruptured Intracranial Aneurysms

Condition: Aneurysmal Subarachnoid Hemorrhage · Endovascular Procedures · Craniotomy  ·  Sponsor: Haaglanden Medical Centre

PhaseN/A
Planned participants880
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored. Furthermore, cost effectiveness and radiological prognostic factors will be examined.

This description comes directly from the study's public registry record.

Talk to the study team

Rick Vreeburg, MD  ·  +31(0)88-9792165  ·  r.j.g.vreeburg@lumc.nl

Wouter Moojen, MD, PhD  ·  w.moojen@haaglandenmc.nl

Always discuss trial participation with your own doctor first.

Locations (6)

Amsterdam UMCAmsterdam, NetherlandsRecruiting
Maastricht UMCMaastricht, NetherlandsRecruiting
RadboudumcNijmegen, NetherlandsRecruiting
Erasmus MCRotterdam, NetherlandsRecruiting
Haaglanden Medical CenterThe Hague, NetherlandsRecruiting
Universitair Medisch Centrum UtrechtUtrecht, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05851989